Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life
Public ClinicalTrials.gov record NCT01214837. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Randomized, Open-Label, Multi-Center Study to Evaluate the Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to assess immunogenicity of a 3-dose versus 4-dose infant vaccination schedule including kinetics of immune response in the early phases of the series.
Study identification
- NCT ID
- NCT01214837
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 751 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 55 Days to 89 Days
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2010 (Type not available)
- Primary completion
- Apr 2012 (Actual)
- Completion
- May 2012 (Actual)
- Last update posted
- Oct 9, 2018
2010 – 2012
United States locations
- U.S. sites
- 37
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Fayetteville | Arkansas | — | — |
| Not listed | Jonesboro | Arkansas | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Fountain Valley | California | — | — |
| Not listed | Huntington Beach | California | — | — |
| Not listed | Madera | California | — | — |
| Not listed | Nampa | Idaho | — | — |
| Cotton ONeil Clinical Research | Topeka | Kansas | 66604 | — |
| Cotton ONeil Clinical Research | Topeka | Kansas | 66614 | — |
| Not listed | Bardstown | Kentucky | — | — |
| Bluegrass Clinical Research (Bardstown Road) | Louisville | Kentucky | — | — |
| Bluegrass Clinical Research (Brownsboro Park Blvd) | Louisville | Kentucky | — | — |
| Not listed | Springfield | Kentucky | — | — |
| Not listed | Haughton | Louisiana | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Niles | Michigan | — | — |
| Not listed | Lincoln | Nebraska | — | — |
| Children's Physicians Dundee | Omaha | Nebraska | — | — |
| Creighton Univ | Omaha | Nebraska | — | — |
| Not listed | Binghamton | New York | — | — |
| Not listed | Johnson City | New York | — | — |
| Not listed | Syracuse | New York | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Huber Heights | Ohio | — | — |
| Not listed | Kettering | Ohio | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Kingsport | Tennessee | — | — |
| Not listed | Lebanon | Tennessee | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Tomball | Texas | — | — |
| Not listed | Layton | Utah | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | St. George | Utah | — | — |
| Not listed | Richmond | Virginia | — | — |
| Rockwood Clinic P S | Spokane | Washington | 99202 | — |
| Rockwood Clinic P S | Spokane | Washington | 99218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01214837, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2018 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01214837 live on ClinicalTrials.gov.